Dáil Éireann Debate, Thursday - 2 July 2015
117. Deputy Clare Daly asked the Minister for Defence the number of soldiers who were administered Mefloquine and Primaquine by the Army, despite having been diagnosed as glucose-6-phosphate dehydrogenase deficiency negative. [26678/15]
Amharc ar fhreagraAs part of the screening process prior to deployment on a mission to a malarious area, an individual’s G6PD status is checked. As a matter of policy, those found to be deficient in G6PD are deemed unsuitable for deployment to a malarious area. While G6PD deficiency is not a contraindication to the use of Lariam (Mefloquine), if the individual is not found suitable for overseas service in a malarious area, he/she will not be required to use Lariam (Mefloquine) or Primaquine.
